# Ciprofloxacin Treatment in Juvenile Mice Involves Neuronal Activation and Mimics Physical Features of Human Disease

**Authors:** Nicole A. Chittim, Amro A. Hussien, Nicolo Dubacher, Gabor Matyas, Jess G. Snedeker

PMC · DOI: 10.1002/jor.70095 · Journal of Orthopaedic Research · 2025-10-28

## TL;DR

Ciprofloxacin treatment in young mice causes tendon changes similar to human tendinopathy, including nerve activation and structural damage.

## Contribution

The study identifies neuronal activation as a novel pathway in fluoroquinolone-induced tendinopathy using a mouse model.

## Key findings

- Ciprofloxacin upregulates nerve development genes and downregulates extracellular matrix genes in mouse tendons.
- Treated mice show reduced mechanical properties and increased apoptotic cells in patellar tendons.
- Ciprofloxacin increases nerve cell presence (Plexin B1+) in patellar tendons compared to controls.

## Abstract

Tendinopathy is a complex, painful condition that affects up to 5% of the general population in their lifetime. Antibiotic treatment with fluoroquinolones has been associated with the onset of tendinopathy and tendon rupture. The mechanisms behind fluoroquinolone induced tendinopathy remain unclear. To probe activation of potentially causative pathways, we treated juvenile mice with ciprofloxacin in drinking water for 4 weeks and performed RNA sequencing on tail tendons. We discovered that ciprofloxacin‐treated mice had upregulated genes relating to nerve development. Additionally, treated mice showed downregulation of genes associated with extracellular matrix (ECM) processes. We further explored ECM changes using histological and mechanical testing methods on patellar tendons. We found that ciprofloxacin treatment led to altered cell morphology and proteoglycan density. These changes translated to a decrease in mechanical properties of the patellar tendons. Furthermore, ciprofloxacin‐treated mice had a higher percentage of apoptotic cells, and we confirmed increased presence of nerve cells (Plexin B1+) in the patellar tendons compared to controls. Taken together, we showed that ciprofloxacin treatment in juvenile mice induces structural and biological phenotypes commonly associated with fluoroquinolone‐induced tendinopathy and identify the axis of pathological neural activation as a promising area for further exploration.

Clinical significance: Oral administration of ciprofloxacin in mice presents a clinically relevant model for studying mechanisms of tendinopathy in humans.

## Linked entities

- **Genes:** PLXNB1 (plexin B1) [NCBI Gene 5364]
- **Chemicals:** ciprofloxacin (PubChem CID 2764)
- **Diseases:** tendinopathy (MONDO:0100010)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Plxnb1 (plexin B1) [NCBI Gene 235611] {aka 2900002G15Rik, mKIAA0407}
- **Diseases:** painful (MESH:D010146), Tendinopathy (MESH:D052256), tendon rupture (MESH:D012421)
- **Chemicals:** fluoroquinolone (MESH:D024841), Ciprofloxacin (MESH:D002939)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12865670/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12865670/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12865670/full.md

---
Source: https://tomesphere.com/paper/PMC12865670